Quick Answer
Arcadia Biosciences, Inc. reported Operating Income of -$2.50 million for fiscal year 2025.
Arcadia Biosciences, Inc. Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2025 | -$2.50M | +31.5% |
| 2024 | -$3.65M | +40.2% |
| 2023 | -$6.10M | +56.4% |
| 2022 | -$14.01M | +60.6% |
| 2021 | -$35.53M | -178.0% |
| 2020 | -$12.78M | +34.1% |
| 2019 | -$19.38M | -14.9% |
| 2018 | -$16.87M | -17.8% |
| 2017 | -$14.31M | +23.1% |
| 2016 | -$18.62M | -19.6% |
| 2015 | -$15.56M | -2.7% |
| 2014 | -$15.15M | — |
Quarterly Operating Income
| Quarter Ending | Operating Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$1.15M | +34.5% | -129.9% |
| June 30, 2025 | -$501.0K | -125.3% | -194.5% |
| March 31, 2025 | $530.0K | +133.4% | +130.1% |
| September 30, 2024 | -$1.76M | -26.0% | -188.9% |
| June 30, 2024 | $1.98M | +236.2% | +224.7% |
| March 31, 2024 | -$1.59M | +58.9% | -13.7% |
| September 30, 2023 | -$1.40M | +65.0% | +3.9% |
| June 30, 2023 | -$1.45M | +61.6% | +62.4% |
- Arcadia Biosciences, Inc. showed an increase of +31.5% in Operating Income compared to the prior fiscal year.
- Over the 2014–2025 period, Arcadia Biosciences, Inc.’s operating income has grown by 83.5% (from -$15.15 million to -$2.50 million).
- The most recent figure is from Arcadia Biosciences, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: